(GRC) Gorman-Rupp - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3830821043
Stock: Pumps, Systems, Centrifugal, Submersible, Dewatering
Total Rating 58
Risk 88
Buy Signal 0.46
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.84% |
| Yield on Cost 5y | 3.11% |
| Yield CAGR 5y | 4.07% |
| Payout Consistency | 95.3% |
| Payout Ratio | 37.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.0% |
| Relative Tail Risk | -9.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.85 |
| Alpha | 60.98 |
| Character TTM | |
|---|---|
| Beta | 0.961 |
| Beta Downside | 0.865 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.87% |
| CAGR/Max DD | 1.34 |
Description: GRC Gorman-Rupp January 20, 2026
Gorman-Rupp (NYSE:GRC) designs, manufactures and sells a broad portfolio of pumps-including self-priming, magnetic-drive, submersible and high-pressure booster units-for water, wastewater, construction, petroleum, agricultural and fire-suppression applications, serving customers worldwide through distributors, OEM partners, direct sales and e-commerce channels.
In FY 2023 the company generated roughly $1.1 billion in revenue, posting an adjusted EBITDA margin of about 13% and a year-over-year earnings-per-share increase of 8%, while its order backlog rose to $210 million, indicating solid demand continuity.
Key macro drivers for Gorman-Rupp include rising U.S. federal and state infrastructure spending on water and wastewater projects, which the American Society of Civil Engineers rates as a high-priority need, and sustained construction activity that fuels demand for dewatering and high-pressure pump solutions.
For a deeper, data-rich perspective on Gorman-Rupp’s valuation and risk profile, you may want to explore the company’s analyst metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 50.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.84 > 1.0 |
| NWC/Revenue: 18.28% < 20% (prev 21.31%; Δ -3.03% < -1%) |
| CFO/TA 0.12 > 3% & CFO 100.5m > Net Income 50.2m |
| Net Debt (279.4m) to EBITDA (117.5m): 2.38 < 3 |
| Current Ratio: 2.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.3m) vs 12m ago 0.24% < -2% |
| Gross Margin: 29.90% > 18% (prev 0.30%; Δ 2960 % > 0.5%) |
| Asset Turnover: 77.40% > 50% (prev 74.43%; Δ 2.97% > 0%) |
| Interest Coverage Ratio: 3.62 > 6 (EBITDA TTM 117.5m / Interest Expense TTM 24.8m) |
Altman Z'' 4.05
| A: 0.14 (Total Current Assets 239.3m - Total Current Liabilities 115.2m) / Total Assets 869.9m |
| B: 0.47 (Retained Earnings 409.8m / Total Assets 869.9m) |
| C: 0.10 (EBIT TTM 89.8m / Avg Total Assets 876.7m) |
| D: 0.85 (Book Value of Equity 394.4m / Total Liabilities 464.7m) |
| Altman-Z'' Score: 4.05 = AA |
Beneish M -3.04
| DSRI: 1.01 (Receivables 92.2m/88.3m, Revenue 678.5m/657.5m) |
| GMI: 1.02 (GM 29.90% / 30.39%) |
| AQI: 0.99 (AQ_t 0.57 / AQ_t-1 0.58) |
| SGI: 1.03 (Revenue 678.5m / 657.5m) |
| TATA: -0.06 (NI 50.2m - CFO 100.5m) / TA 869.9m) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of GRC shares?
As of February 07, 2026, the stock is trading at USD 65.70 with a total of 190,658 shares traded.
Over the past week, the price has changed by +20.57%, over one month by +32.49%, over three months by +47.07% and over the past year by +77.01%.
Over the past week, the price has changed by +20.57%, over one month by +32.49%, over three months by +47.07% and over the past year by +77.01%.
Is GRC a buy, sell or hold?
Gorman-Rupp has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy GRC.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GRC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 59 | -10.2% |
| Analysts Target Price | 59 | -10.2% |
| ValueRay Target Price | 86.1 | 31% |
GRC Fundamental Data Overview January 31, 2026
P/E Trailing = 28.6126
P/E Forward = 19.6464
P/S = 2.1193
P/B = 3.5492
P/EG = 1.5117
Revenue TTM = 678.5m USD
EBIT TTM = 89.8m USD
EBITDA TTM = 117.5m USD
Long Term Debt = 301.5m USD (from longTermDebt, last quarter)
Short Term Debt = 20.8m USD (from shortTermDebt, last quarter)
Debt = 322.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 279.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.72b USD (1.44b + Debt 322.3m - CCE 42.9m)
Interest Coverage Ratio = 3.62 (Ebit TTM 89.8m / Interest Expense TTM 24.8m)
EV/FCF = 17.80x (Enterprise Value 1.72b / FCF TTM 96.5m)
FCF Yield = 5.62% (FCF TTM 96.5m / Enterprise Value 1.72b)
FCF Margin = 14.22% (FCF TTM 96.5m / Revenue TTM 678.5m)
Net Margin = 7.41% (Net Income TTM 50.2m / Revenue TTM 678.5m)
Gross Margin = 29.90% ((Revenue TTM 678.5m - Cost of Revenue TTM 475.6m) / Revenue TTM)
Gross Margin QoQ = 27.39% (prev 31.31%)
Tobins Q-Ratio = 1.97 (Enterprise Value 1.72b / Total Assets 869.9m)
Interest Expense / Debt = 1.80% (Interest Expense 5.79m / Debt 322.3m)
Taxrate = 26.02% (3.99m / 15.3m)
NOPAT = 66.4m (EBIT 89.8m * (1 - 26.02%))
Current Ratio = 2.08 (Total Current Assets 239.3m / Total Current Liabilities 115.2m)
Debt / Equity = 0.80 (Debt 322.3m / totalStockholderEquity, last quarter 405.2m)
Debt / EBITDA = 2.38 (Net Debt 279.4m / EBITDA 117.5m)
Debt / FCF = 2.90 (Net Debt 279.4m / FCF TTM 96.5m)
Total Stockholder Equity = 389.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.73% (Net Income 50.2m / Total Assets 869.9m)
RoE = 12.89% (Net Income TTM 50.2m / Total Stockholder Equity 389.7m)
RoCE = 12.98% (EBIT 89.8m / Capital Employed (Equity 389.7m + L.T.Debt 301.5m))
RoIC = 9.04% (NOPAT 66.4m / Invested Capital 734.2m)
WACC = 7.97% (E(1.44b)/V(1.76b) * Re(9.46%) + D(322.3m)/V(1.76b) * Rd(1.80%) * (1-Tc(0.26)))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.18%
[DCF Debug] Terminal Value 79.64% ; FCFF base≈87.1m ; Y1≈96.5m ; Y5≈125.5m
Fair Price DCF = 72.18 (EV 2.18b - Net Debt 279.4m = Equity 1.90b / Shares 26.3m; r=7.97% [WACC]; 5y FCF grow 12.48% → 2.90% )
EPS Correlation: 33.79 | EPS CAGR: -45.18% | SUE: -4.0 | # QB: 0
Revenue Correlation: 77.61 | Revenue CAGR: 17.58% | SUE: -0.45 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.53 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.25 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+11.9% | Growth Revenue=+4.5%
P/E Forward = 19.6464
P/S = 2.1193
P/B = 3.5492
P/EG = 1.5117
Revenue TTM = 678.5m USD
EBIT TTM = 89.8m USD
EBITDA TTM = 117.5m USD
Long Term Debt = 301.5m USD (from longTermDebt, last quarter)
Short Term Debt = 20.8m USD (from shortTermDebt, last quarter)
Debt = 322.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 279.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.72b USD (1.44b + Debt 322.3m - CCE 42.9m)
Interest Coverage Ratio = 3.62 (Ebit TTM 89.8m / Interest Expense TTM 24.8m)
EV/FCF = 17.80x (Enterprise Value 1.72b / FCF TTM 96.5m)
FCF Yield = 5.62% (FCF TTM 96.5m / Enterprise Value 1.72b)
FCF Margin = 14.22% (FCF TTM 96.5m / Revenue TTM 678.5m)
Net Margin = 7.41% (Net Income TTM 50.2m / Revenue TTM 678.5m)
Gross Margin = 29.90% ((Revenue TTM 678.5m - Cost of Revenue TTM 475.6m) / Revenue TTM)
Gross Margin QoQ = 27.39% (prev 31.31%)
Tobins Q-Ratio = 1.97 (Enterprise Value 1.72b / Total Assets 869.9m)
Interest Expense / Debt = 1.80% (Interest Expense 5.79m / Debt 322.3m)
Taxrate = 26.02% (3.99m / 15.3m)
NOPAT = 66.4m (EBIT 89.8m * (1 - 26.02%))
Current Ratio = 2.08 (Total Current Assets 239.3m / Total Current Liabilities 115.2m)
Debt / Equity = 0.80 (Debt 322.3m / totalStockholderEquity, last quarter 405.2m)
Debt / EBITDA = 2.38 (Net Debt 279.4m / EBITDA 117.5m)
Debt / FCF = 2.90 (Net Debt 279.4m / FCF TTM 96.5m)
Total Stockholder Equity = 389.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.73% (Net Income 50.2m / Total Assets 869.9m)
RoE = 12.89% (Net Income TTM 50.2m / Total Stockholder Equity 389.7m)
RoCE = 12.98% (EBIT 89.8m / Capital Employed (Equity 389.7m + L.T.Debt 301.5m))
RoIC = 9.04% (NOPAT 66.4m / Invested Capital 734.2m)
WACC = 7.97% (E(1.44b)/V(1.76b) * Re(9.46%) + D(322.3m)/V(1.76b) * Rd(1.80%) * (1-Tc(0.26)))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.18%
[DCF Debug] Terminal Value 79.64% ; FCFF base≈87.1m ; Y1≈96.5m ; Y5≈125.5m
Fair Price DCF = 72.18 (EV 2.18b - Net Debt 279.4m = Equity 1.90b / Shares 26.3m; r=7.97% [WACC]; 5y FCF grow 12.48% → 2.90% )
EPS Correlation: 33.79 | EPS CAGR: -45.18% | SUE: -4.0 | # QB: 0
Revenue Correlation: 77.61 | Revenue CAGR: 17.58% | SUE: -0.45 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.53 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.25 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+11.9% | Growth Revenue=+4.5%